APN 2020 - November 18-19
Dear Colleagues,
On behalf of the Asian Pharmacometrics Network (APN), it is my great pleasure
to announce the 2020 APN Symposium to be held virtually on November 18-19.
The APN was created to enhance regional development and networking
opportunities in pharmacometrics and to provide training opportunities to
future pharmacometricians across Asia. Currently the APN has 14 member
countries, and the detail is found at http://www.go-apn.org/.
At the APN meeting this year, speakers invited from more than10 Asian countries
will present on various topics, which will make the APN meeting a unique
pan-Asian forum in the region. In particular, students will be invited to
podium presentations to encourage the participation of future
pharmacometricians.
As a post-symposium event, on November 20, there will be a pharmacometrics
workshop for Julia Hub, organized by PUMAS-AI.
For both symposium and workshop, registration is free and its procedure and the
program are found at https://www.sophas.net/apn2020.php. For more information,
contact the local host Dr. Surulivelrajan Mallayasamy of Manipal Academy of
Higher Education of India at
[email protected]<mailto:[email protected]>
Best regards,
APN Chair
Kyungsoo Park
---------------------------------------
Kyungsoo Park, PhD, MD
Professor of Pharmacology
Yonsei University College of Medicine
50-1 Yonsei-Ro, Seoul 03722, Korea
Tel +82-2-2228-1735 / Fax +82-2-313-1894
상기 메일은 지정된 수신인 만을 위한 것이며 부정경쟁 방지 및 영업비밀보호에 관한 법률을 포함하여 관련 법령에 따라 보호의 대상이 되는
영업비밀, 산업기술 등을 포함하고 있을 수 있습니다. 본 문서에 포함된 정보의 전부 또는 일부를 무단으로 제3자에게 공개, 배포, 복사 또는
사용하는 것은 엄격히 금지됩니다. 본 메일이 잘못 전송된 경우, 발신인에게 알려주시고 즉시 삭제하여 주시기 바랍니다. The above
message is intended solely for the named addressee and may contain trade
secret, industrial technology or privileged and confidential information
otherwise protected under applicable law including the Unfair Competition
Prevention and Trade Secret protection act. Any unauthorized dissemination,
distribution, copying or use of the information contained in this communication
is strictly prohibited. If you have received this communication in error,
please notify the sender by email and delete this communication immediately.